Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia
在 ASPECT-NP 随机对照 III 期临床试验中,比较头孢洛扎/他唑巴坦和美罗培南治疗医院获得性/呼吸机相关性细菌性肺炎的疗效,并按致病菌分析临床和微生物学结果。
期刊:Journal of Antimicrobial Chemotherapy
影响因子:3.6
doi:10.1093/jac/dkab494
Martin-Loeches, Ignacio; Timsit, Jean-François; Kollef, Marin H; Wunderink, Richard G; Shime, Nobuaki; Nováček, Martin; Kivistik, Ülo; Réa-Neto, Álvaro; Bruno, Christopher J; Huntington, Jennifer A; Lin, Gina; Jensen, Erin H; Motyl, Mary; Yu, Brian; Gates, Davis; Butterton, Joan R; Rhee, Elizabeth G